Inhibition of malignant activities of nasopharyngeal carcinoma cells with high expression of CD44 by siRNA

Oncology Reports

Volumn 18, Issue 2, 2007, Pages 397-403

  Shi, Y ^a   Tian, Y ^a   Zhou, Y Q ^a   Ju, J Y ^a   Qu, L ^a   Chen, S L ^a   Xiang, Z G ^a   Liu, Y ^a   Zhu, L P ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

CD44; Malignant activities; siRNA; Therapy; Tumor

Indexed keywords

CADHERIN; HERMES ANTIGEN; SMALL INTERFERING RNA;

ADENOVIRUS; ANIMAL; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DRUG SCREENING; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD44; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34548527034     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.2.397     Document Type: Article

References (30)

1. Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003. (Pubitemid 36077255)
2. Naor D, Nedvetzki S, Golan I, Melnik L and Faitelson Y: CD44 in cancer. Crit Rev Clin Lab Sci 39: 527-579, 2002. (Pubitemid 35425379)
3. Marhaba R and Zoller M: CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231, 2004. (Pubitemid 40585308)
4. Breyer R, Husein S, Radu DL, Putz KM, Gunia S, Hecker H, Sammi M, Walter F and Stan AC: Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody. J Neurosurg 92: 140-149, 2000. (Pubitemid 30022098)
5. Zahalka MA, Okon E, Gosslar U, Holzmann B and Naor D: Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol 154: 5345-5355, 1995.
6. Strobel T, Swanson L and Cannistra SA: In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. Cancer Res 57: 1228-1232, 1997. (Pubitemid 27152541)
7. Sy MS, Guo YJ and Stamenkovic I: Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med 176: 623-627, 1992.
8. Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, Sasaki I and Matsuno S: Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91: 67-75, 2001.
9. Reeder JA, Gotley DC, Walsh MD, Fawcett J and Antalis TM: Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 58: 3719-3726, 1998. (Pubitemid 28376574)
10. Bankfafalvi A, Terpe HJ, Breukelmann D, Bier B, Rempe D, Pschadka G, Krech R and Bocker W: Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology 33: 107-116, 1998. (Pubitemid 28387019)
11. Friedrichs K, Franke F, Lisboa BW, Kugler G, Gille I, Terpe HJ, Holzel F, Maass H and Gunthert U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55: 5424-5433, 1995.
12. Yokota J: Tumor progression and metastasis. Carcinogenesis 21: 497-503, 2000.
13. Cairns RA, Khokha R and Hill RP: Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 39: 659-671, 2003. (Pubitemid 37236408)
14. Ghaffari S, Dougherty GJ, Eaves AC and Eaves CJ: Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia 10: 1773-1781, 1996. (Pubitemid 26380024)
15. Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, Robert-Lezenes J, Chomienne C and Smadja-Joffe F: The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk Lymphoma 45: 1501-1510, 2004. (Pubitemid 38885991)
16. Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C and Smadja-Joffe F: Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 5: 669-676, 1999. (Pubitemid 29289431)
17. Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, Jasmin C, Chomienne C and Smadja-Joffe F: Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 99: 290-299, 2002.
18. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F and Dick JE: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12: 1167-1174, 2006. (Pubitemid 44527352)
19. Yu DN and Gao J: Study on the invasive properties of cloned human nasopharyngeal carcinoma CNE-2L2 variants using organ culture in vitro. Acta Acad Med Sinicae (in Chinese) 16: 317-321, 1994.
20. Yue W, Jin YL, Shi GX, Liu Y, Gao Y, Zhao FT and Zhu LP: Suppression of 6A8 α-mannosidase gene expression reduced the potentiality of growth and metastasis of human nasopharyngeal carcinoma. Int J Cancer 108: 189-195, 2004. (Pubitemid 37541769)
21. Liu CM, Liu DP, Dong WJ and Liang CC: Retrovirus vector-mediated stable gene silencing in human cell. Biochem Biophys Res Commun 313: 716-720, 2004.
22. Chen SL, Shi Y, Jin YL, Liu Y, Zhao FT and Zhu LP: Differential gene expression in nasopharyngeal carcinoma cell with reduced and normal expression of 6A8 α-mannosidase. Acta Acad Med Sinicae (in Chinese) 27: 305-310, 2005.
23. Breyer R, Husein S, Radu DL, Putz KM, Gunia S, Hecker H, Sammi M, Walter F and Stan AC: Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody. J Neurosurg 92: 140-149, 2000. (Pubitemid 30022098)
24. Seiter S, Arch R, Reber S, Komitovski D, Hofmann M, Ponta H, Herrlich P, Matzku S and Zoller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443-455, 1993. (Pubitemid 23117094)
25. Zawadski V, Perschl A, Rosel M, Hekele A and Zoller M: Blockade of metastasis formation by CD44-receptor globulin. Int J Cancer 75: 919-924, 1998. (Pubitemid 28134118)
26. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M and Sy MS: Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54: 1561-1565, 1994. (Pubitemid 24106423)
27. Avin E, Haimovich J and Hollander N: Anti-idiotype x anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma. J Immunol 173: 4736-4743, 2004. (Pubitemid 39280710)
28. Pecina-Slaus N: Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 3: 17-23, 2003.
29. Takeishi M: Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811, 1993.
30. Beavon IRG: The E-cadharin-catanin complex in tumor metastasis: structure, function and regulation. Eur J Cancer 46: 247-256, 2000.